BioGend Therapeutics Co., Ltd. (TPEX: 6733)
37.00
+0.40 (1.09%)
Sep 11, 2024, 9:20 AM CST
BioGend Therapeutics Market Cap
BioGend Therapeutics has a market cap or net worth of 4.55 billion as of September 10, 2024. Its market cap has increased by 0.14% in one year.
Market Cap
4.55B
Enterprise Value
3.91B
Revenue
133.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
37.00
Market Cap Chart
Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 4.55B, an increase of 67.55%. That is a compound annual growth rate of 10.36%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 10, 2024 | 4.55B | -3.40% |
Dec 29, 2023 | 4.71B | 109.50% |
Dec 30, 2022 | 2.25B | -18.50% |
Dec 30, 2021 | 2.76B | -22.86% |
Dec 31, 2020 | 3.57B | 46.27% |
Dec 31, 2019 | 2.44B | -9.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition